Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News


Supported by an $86 Million Round, First Bio-Artificial Liver Moves Toward Pivotal Trials 

 

 

Supported by an $86 Million Round, First Bio-Artificial Liver Moves Toward Pivotal Trials

November 9, 2012 - (MEDCITY News) - "Vital Therapies says it has the world’s first cell-based, bio-artificial liver designed to stabilize liver funnction in patients with life-threatening acute liver failure, and it’s headed for pivotal trials. Called Elad, the device has survived two companies that went bankrupt after spending $65 million developing it, according to Forbes."  Read Full Article

 

Posted on 27-Nov-12 by Gallerno, Jacob
Tags: Science and Industry News
 
Trackback Url  |  Link to this post | Bookmark this post with: